D. Boral Capital Cuts Carisma Therapeutics (NASDAQ:CARM) Price Target to $12.00
Carisma Therapeutics (NASDAQ:CARM – Get Free Report) had its price target cut by analysts at D. Boral Capital from $24.00 to $12.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. CARM has been the subject of several other research reports. HC Wainwright dropped their […]
More Stories
Alpha Real Trust (LON:ARTL) Stock Price Up 11.9% – Should You Buy?
Alpha Real Trust Limited (LON:ARTL – Get Free Report) traded up 11.9% on Tuesday . The stock traded as high...
BKV (NYSE:BKV) Sets New 52-Week High – Here’s What Happened
Shares of BKV Corporation (NYSE:BKV – Get Free Report) hit a new 52-week high on Tuesday . The company traded...
Symbotic (NASDAQ:SYM) Trading Up 9% – Here’s Why
Symbotic Inc. (NASDAQ:SYM – Get Free Report) rose 9% on Tuesday . The stock traded as high as $32.05 and...
Enerflex (NYSE:EFXT) Sets New 12-Month High – Here’s Why
Enerflex Ltd. (NYSE:EFXT – Get Free Report)’s stock price reached a new 52-week high on Tuesday . The stock traded...
FTI Consulting (NYSE:FCN) Sees Strong Trading Volume – What’s Next?
FTI Consulting, Inc. (NYSE:FCN – Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 286,590 shares were...
Recent Analysts’ Ratings Updates for Honeywell International (HON)
A number of research firms have changed their ratings and price targets for Honeywell International (NASDAQ: HON): 1/17/2025 – Honeywell...